RGX-014

N/A

Report date: 2024/11/29 11:23:38

Base Information

Drug NameRGX-014
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInsulin-like growth factor binding protein II modulators
TargetsInsulin-like growth factor binding protein II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInspirna Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInspirna Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A